who should not take semaglutide Weight loss & Ozempic have become synonymous terms! Aside from becoming an absolute game changer in type two diabetic management, semaglutide's ability to assist with weight management has changed the future of Who Should Not Take Wegovy?

The Need for More Research in the GLP1 Era Despite growing anecdotal reports, the sensory-related side effects of GLP1s remain largely under-researched

Semaglutide is a weight loss drug that targets the glucagon-like peptide-1 (GLP-1), sold by Novo Nordisk under the brand name Wegovy to treat people with obesity and under Ozempic to treat patients with both type 2 diabetes and obesity

Lancet Psychiatry 3 , 171178 (2016)

GLP-1 Medications FAQ Can I work out while on GLP-1 Medications

Eur J Pharmacol 281 : 8188 Fritz IB

Their contributions are directly improving patient experiences and outcomes in a very tangible way. Link out Published on: September 04, 2025 XanderCare Xander Garanzuay, a long-distance runner, never imagined his high school track meet would end with him being airlifted to the hospital